Current Report Filing (8-k)
September 25 2019 - 5:01PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND
EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to
Section 13 or 15(d)
of the Securities
Exchange Act of 1934
Date of Report
(Date of earliest event reported): September 24, 2019
Innovative Industrial
Properties, Inc.
(Exact name
of registrant as specified in its charter)
Maryland
|
|
001-37949
|
|
81-2963381
|
(State or Other Jurisdiction
of Incorporation)
|
|
(Commission
File No.)
|
|
(I.R.S. Employer
Identification No.)
|
11440 West Bernardo
Court, Suite 220
San Diego, California
92127
(Address of
principal executive offices, including zip code)
Registrant’s
telephone number, including area code: (858) 997-3332
Check the appropriate box below if
the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions
(see General Instruction A.2. below):
|
¨
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
¨
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
¨
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c)
under the Exchange Act (17 CFR 240.13e-4(c))
|
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company
x
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Securities Registered pursuant to Section 12(b) of the Act:
Title of each class
|
|
Trading Symbol(s)
|
|
Name of each exchange on which registered
|
Common Stock, par value $0.001 per share
|
|
IIPR
|
|
New York Stock Exchange
|
Series A Preferred Stock, par value $0.001 per share
|
|
IIPR-PA
|
|
New York Stock Exchange
|
Item 1.01. Entry into
a Material Definitive Agreement.
On
September 24, 2019, IIP-MA 1 LLC (“Landlord”), a wholly owned subsidiary of IIP Operating Partnership, LP (the “Operating
Partnership”), the operating partnership subsidiary of Innovative Industrial Properties, Inc. (the “Company”),
entered into an amendment (the “Lease Amendment”) to its lease (the “Lease”) with Pharmacannis Massachusetts
Inc. (“Tenant”), a subsidiary of PharmaCann LLC, for the property located at 465 Hopping Brook Road, Holliston, Massachusetts
(the “Property”), and entered into an amendment (the “Development Agreement Second Amendment”) to the development
agreement (the “Development Agreement”) by and among Landlord, the Operating Partnership and Tenant.
The
Development Agreement Second Amendment provides for funding to Tenant of up to an additional $8.0 million for additional development
at the Property (the “Additional Funding”). If the Company funds the full amount of the Additional Funding, the Company’s
total investment in the Property is expected to be $26.5 million.
The
provision of the Additional Funding resulted in a corresponding adjustment of the base rent and the security deposit under the
Lease Amendment. The Lease Amendment also extends the initial term of the Lease to September 24, 2034.
Landlord,
the Operating Partnership and Tenant previously entered into a first amendment to the Development Agreement (the “Development
Agreement First Amendment”) to make certain minor clarifications to the recitals of the Development Agreement, including
an update to the description of the Property to include the new Property address.
The
foregoing descriptions of the Lease Amendment, the Development Agreement First Amendment and the Development Agreement Second Amendment
do not purport to be complete and are qualified in their entirety by reference to the complete text of the Lease Amendment, the
Development Agreement First Amendment and the Development Agreement Second Amendment, which are filed as exhibits to this report
and incorporated herein by reference.
Item 9.01. Financial Statements
and Exhibits.
Exhibit
|
|
Description
of Exhibit
|
|
|
10.1
|
|
Second Amendment dated September 24, 2019 to Lease Agreement dated May 31, 2018 between IIP-MA 1 LLC and PharmaCannis Massachusetts Inc.
|
10.2
|
|
First Amendment dated July 26, 2019 to Development Agreement dated May 31, 2018 between IIP-MA 1 LLC, IIP Operating Partnership, LP and PharmaCannis Massachusetts Inc.
|
10.3
|
|
Second Amendment dated September 24, 2019 to Development Agreement dated May 31, 2018 between IIP-MA 1 LLC, IIP Operating Partnership, LP and PharmaCannis Massachusetts Inc.
|
SIGNATURES
Pursuant to the
requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Date: September 25, 2019
|
INNOVATIVE INDUSTRIAL PROPERTIES, INC.
|
|
|
|
|
|
|
|
By:
|
/s/ Catherine Hastings
|
|
Name:
|
Catherine Hastings
|
|
Title:
|
Chief Financial Officer, Chief Accounting Officer and Treasurer
|
Innovative Industrial Pr... (NYSE:IIPR)
Historical Stock Chart
From Aug 2024 to Sep 2024
Innovative Industrial Pr... (NYSE:IIPR)
Historical Stock Chart
From Sep 2023 to Sep 2024